| ID | Sequence | Length | GC content |
|---|---|---|---|
| AGUUGAGCUUGGGGACUGCAGCUGUGGGGAGAUUUCAGUGCAUUGCCUC… | 1876 nt | 0.4925 | |
| AGUUGAGCUUGGGGACUGCAGCUGUGGGGAGAUUUCAGUGCAUUGCCUC… | 1813 nt | 0.4937 | |
| AAGAGCAAGGAACAACCCAUUUCGUCGUUAUGAUUAUUCCUUGGGCCUG… | 1774 nt | 0.4899 | |
| AAGAGCAAGGAACAACCCAUUUCGUCGUUAUGGUAAGUGGAGAUUAUUC… | 1784 nt | 0.4899 |
Enables integrin binding activity and protein homodimerization activity. Involved in heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules and myeloid leukocyte migration. Located in bicellular tight junction; nucleoplasm; and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
A study in humans developed and validated an mRNA-cSNP panel for simultaneous body fluid identification and individualization, where the JAML was included as a venous blood-specific mRNA gene and cSNP marker (rs1793174, rs2298831) for both identification and donor individualization [Zhiyong Liu et al. DOI:10.1007/s00414-025-03434-0]. Another human study using whole transcriptome shotgun sequencing on low-template blood samples identified the JAML gene as a candidate blood-specific mRNA biomarker and identified several SNPs within it as candidate body fluid identification markers [Jepsen et al. DOI:10.1016/j.fsigen.2024.103089]. A study in humans demonstrated that the JAML functions as an mRNA marker for blood identification and was used as a leukocyte marker in a forensic multiplex PCR system [van den Berge et al. DOI:10.1016/j.fsigen.2015.10.011]. A subsequent human study targeting coding region single nucleotide polymorphisms (cSNPs) for donor association included two cSNPs in the JAML gene, with RNA samples from blood aligning mainly with the JAML and ANK1, and these markers contributed to a high power of discrimination for blood [Trnka et al. DOI:10.1016/J.Fsigen.2026.103455].